News

Both of us have dedicated our careers to advancing food safety and protecting the public. We’ve both done so at the height of federal service, in academic settings, as well as within the private sector. That’s why we believe we’re well qualified to…

Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the…

EPA’s James “Jim” Jones was named Wednesday as the first FDA Deputy Commissioner for Human Foods.  In an expanded position, he will fill the voids left at the FDA by the February departure of Frank Yiannas, who was the Deputy Commission for the then…

Today, the U.S. Food and Drug Administration is announcing the selection of James “Jim” Jones to serve as the first Deputy Commissioner for Human Foods. The new executive position will lead the charge in setting and advancing priorities for a proposed…

The Food and Drug Administration on Wednesday announced the selection of its first deputy commissioner for human foods — part of an effort to reorganize the agency’s oversight of food safety after contaminated baby formula caused major shortages last…

The U.S. Food and Drug Administration (FDA) has opened a docket to seek public comment on a report outlining a potential framework for establishing a public-private partnership (PPP) to collect and analyze antimicrobial use (AMU) data from food-…

On June 29, Dr. Brian King, director of the Center for Tobacco Products (CTP) at the FDA, issued an update on CTP’s efforts to address the 15 recommendations outlined in a report by an independent expert panel facilitated by the Reagan-Udall Foundation.

Officials with the FDA are seeking feedback from the public on a report1 outlining a potential framework for establishing a public-private partnership (PPP) to collect and analyze antimicrobial use (AMU) data from food-producing animals. The report was…

The Reagan-Udall Foundation for the U.S. Food and Drug Administration (FDA) has published a new report, titled, Establishing a Draft Framework for a Public-Private Partnership to Support the Tracking of Antimicrobial Use in Food-Producing Animals.

Experts told our Robert King at POLITICO’s Next Generation of Health Care Therapies event Thursday that they’re excited about the potential for artificial intelligence to help develop and test gene therapies to treat rare diseases. Read more